Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Journal of Pharmaceutical and Biomedical Analysis|September 1, 1996
Development of HPLC plasma assays for CAM 4515 and CAM 4750, two new nonpeptide tachykinin antagonists, and application to bioavailability studiesT Van Noord, D S Wright, B S Kuo
Biomedical Chromatography : BMC|March 1, 1995
A sensitive high-performance liquid chromatographic assay for the cholecystokinin-B antagonist, CI-988, in human and monkey plasmaJ P Hinton, K Jennings, E L Johnson, et al.
Age and Ageing|August 1, 1979
Dysrhythmias in apparently healthy elderly subjectsM D Clee, N Smith, G P McNeill, et al.
Journal of Pharmaceutical and Biomedical Analysis|April 16, 1998
Sample pooling to expedite bioanalysis and pharmacokinetic researchB S Kuo, T Van Noord, M R Feng, et al.
Journal of Chromatography. B, Biomedical Applications|March 10, 1995
Sensitive high-performance liquid chromatographic method for a dopamine receptor agonist, CI-1007, and its metabolite PD 147693 in monkey plasmaM R Feng, P R Siersma, C A Strenkoski, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|May 23, 1997
Determination of two CI-1007 sulfate metabolites in monkey plasma and urineM R Feng, J Atherton, S Knoll, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1996
Disposition kinetics of human epidermal growth factor (hEGF1-53) and its truncated fragment (hEGF1-48) in ratsB S Kuo, G D Nordblom, R C Dudeck, et al.
Analytical Biochemistry|June 1, 1988
Sequestration electrochemistry: the interaction of chlorpromazine and human orosomucoidD S Wright, M L Friedman, S H Jenkins, et al.
Journal of Clinical Pharmacology|November 1, 1994
Diuretic effects, pharmacokinetics, and safety of a new centrally acting kappa-opioid agonist (CI-977) in humansP A Reece, A J Sedman, S Rose, et al.
Pageof 7